CRDL

Cardiol Therapeutics Inc Class A

Price

$1.89

return (12m)

69.04%

p/e

-230.17

p/bv

DIVIDEND YIELD

0.00%

CRDL price

Cardiol Therapeutics Inc Class A

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CRDL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

1.52%

3 months

78.61%

1 year

69.04%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals CRDL

Valuation

P/E

-230.17

Sector 7.84

Industry 7.84

P/BV

Sector 1.84

Industry 1.84

P/Revenue (PSR)

Sector 1.78

Industry 1.78

EV/EBITDA

2,417,857,087.89

Sector -57.74

Industry -57.74

EV/EBIT

-94,422.13

Sector -289.61

Industry -289.61

P/EBITDA

Sector -9.38

Industry -9.38

P/EBIT

Sector -9.71

Industry -9.71

P/Total Assets

Sector 0.86

Industry 0.86

P/Net Current Assets

Sector -2.04

Industry -2.04

P/Working Capital

Sector -4,847.72

Industry -4,847.72

EPS

-0.01

Sector 0.73

Industry 0.73

BVPS

0.00

Sector 9.89

Industry 9.89

Efficiency

Gross Margin

-100.00%

Sector 35.14%

Industry 35.14%

EBITDA Margin

100.00%

Sector 7.88%

Industry 7.88%

EBIT Margin

-2,560,688.89%

Sector -7.02%

Industry -7.02%

Operating Margin

-100.00%

Sector 4.32%

Industry 4.32%

Net Profit Margins

-100.00%

Sector 2.76%

Industry 2.76%

Asset Turnover

1.00

Sector 0.11

Industry 0.11

Profitability

ROE

Sector 2.49%

Industry 2.49%

ROA

Sector -0.64%

Industry -0.64%

ROIC

Sector -117.48%

Industry -117.48%

Dividends

Dividend yield

0.00%

Sector 0.50%

Industry 0.50%

Payout

Sector 9.69%

Industry 9.69%

Debt

Current Ratio

Sector 1.46

Industry 1.46

Net Debt / EBITDA

0.00

Sector -20.28

Industry -20.28

Net Debt / EBIT

0.00

Sector -165,634,871.06

Industry -165,634,871.06

Net Debt / Equity

0.00

Sector -0.77

Industry -0.77

Gross Debt / Equity

1.00

Sector 0.06

Industry 0.06

Equity/Assets

1.00

Sector 0.43

Industry 0.43

Liabilities/Assets

1.00

Sector 0.53

Industry 0.53

Growth

5Y Revenue CAGR

-2.64%

Sector -

Industry -

5Y Earnings CAGR

748.99%

Sector -

Industry -

Fundamentals CRDL

DRAG THE FRAME TO SEE MORE DATA

CRDL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Cardiol Therapeutics Inc Class A

Cardiol Therapeutics Inc Class A

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

2019

Time since IPO - 7 years

18

Employees

Cardiol Therapeutics Inc Class A (United States) is listed on the Nasdaq and has a market capitalization of $217.61 million, with shareholders equity totaling $0.09.

The company employs approximately 18 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Cardiol Therapeutics Inc Class A reported $0.10 in revenue, generating net income of $-945.44 Thousand.

Key financial metrics include a P/E ratio of -230.17, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CRDL.

Market cap

$217.61 million

Net worth

$0.09

Assets

$0.09

Total Shares Outstanding

114.94 million

114,935,000

Average Daily Trading Volume

$39.77 Thousand

$39,773.24

Sector

Others

Industry

Others

CRDL

CRDL revenue and profits

Financial Results CRDL

DRAG THE FRAME TO SEE MORE DATA

CRDL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$374.03 14,05% (12M)

P/E

22.48

2.41%

ROE

14.27%

P/BV

3.21

SHEL - Shell PLC ADR

$94.75 38,99% (12M)

P/E

10.11

3.98%

ROE

14.29%

P/BV

1.44

STLA - Stellantis NV

$4.82 --51,25% (12M)

P/E

-0.55

0.00%

ROE

-35.93%

P/BV

0.20

COR - Cencora Inc.

$307.93 6,98% (12M)

P/E

22.65

0.78%

ROE

81.08%

P/BV

18.36

ALIZY - Allianz SE ADR

$50.57 --9,44% (12M)

P/E

13.94

2.69%

ROE

17.89%

P/BV

2.49

TTE - TotalEnergies SE ADR

$90.89 58,75% (12M)

P/E

7.30

4.46%

ROE

21.42%

P/BV

1.56

NSRGY - Nestle SA ADR

$92.61 5,71% (12M)

P/E

11.12

4.33%

ROE

58.05%

P/BV

6.46

ELV - Elevance Health Inc

$407.90 32,76% (12M)

P/E

20.04

1.69%

ROE

9.84%

P/BV

1.97